Kristen E. Dew

Kristen E. Dew

Auto-generated profile, based on publicly available information

Kristen E. Dew

Department of Biomedical Research, National Jewish Health, Denver, CO 2

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
RLRobin S. Lindsay
Robin S. Lindsay
JWJennifer C. Whitesell
Jennifer C. Whitesell
KDKristen E. Dew
Kristen E. Dew
ERErika Rodriguez
Erika Rodriguez
ASAdam M. Sandor
Adam M. Sandor
RFRachel S. Friedman
Rachel S. Friedman
Understanding mechanisms of immune regulation is key to developing immunotherapies for autoimmunity and cancer. We examined the role of mononuclear phagocytes during peripheral T cell regulation in type 1 diabetes and melanoma. MERTK expression and activity in mononuclear phagocytes in the pancreatic islets promoted islet T cell regulation, resulting in reduced sensitivity of T cell scanning for cognate antigen in prediabetic islets. MERTK-dependent regulation led to reduced T cell activation and effector function at the disease site in islets and prevented rapid progression of type 1 diabetes. In human islets, MERTK-expressing cells were increased in remaining insulin-containing islets of type 1 diabetic patients, suggesting that MERTK protects islets from autoimmune destruction. MERTK also regulated T cell arrest in melanoma tumors. These data indicate that MERTK signaling in mononuclear phagocytes drives T cell regulation at inflammatory disease sites in peripheral tissues through a mechanism that reduces the sensitivity of scanning for antigen leading to reduced responsiveness to antigen.